# A Clinical Study of HRS-5765 in Healthy Participants

> **NCT07551167** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Chengdu Suncadia Medicine Co., Ltd.** · enrollment: 74 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** HRS-5765 Tablet
- **DRUG:** HRS-5765 Tablet Placebo

## Key facts

- **NCT ID:** NCT07551167
- **Lead sponsor:** Chengdu Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07551167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07551167, "A Clinical Study of HRS-5765 in Healthy Participants". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07551167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*